What is the CVSS score of CVE-2024-27110?

CVE-2024-27110 has a CVSS 3.1 base score of 8.4 (High). CVSS vector: CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H. EPSS exploitation probability: 0.3%.

GE HealthCare EchoPAC CVE-2024-27110

HIGH

Execution with Unnecessary Privileges (CWE-250)

2024-05-14 171caf72-b841-4e04-a68e-93493aff2b94

Privilege Escalation

8.4

CVSS 3.1 · Vendor: 171caf72-b841-4e04-a68e-93493aff2b94

Severity by source

Vendor (171caf72-b841-4e04-a68e-93493aff2b94) PRIMARY

8.4 HIGH

AV:A/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

Primary rating from Vendor (171caf72-b841-4e04-a68e-93493aff2b94) · only source for this CVE.

CVSS VectorVendor: 171caf72-b841-4e04-a68e-93493aff2b94

CVSS:3.1/AV:A/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

Attack Vector

Adjacent

Attack Complexity

Low

Privileges Required

High

User Interaction

None

Scope

Changed

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

May 14, 2024 - 18:15 cve.org

HIGH 8.4

DescriptionCVE.org

Elevation of privilege vulnerability in GE HealthCare EchoPAC products

AnalysisAI

Elevation of privilege vulnerability in GE HealthCare EchoPAC products. Rated high severity (CVSS 8.4), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-250. Elevation of privilege vulnerability in GE HealthCare EchoPAC products

Affected ProductsAI

See vendor advisory for affected versions.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.